Abstract
Multiple comorbidities can mean that some patients with critical limb ischaemia are unsuitable for bypass surgery. Percutaneous transluminal balloon angioplasty (PTA) is currently the predominant nonsurgical intervention, but data from the ACHILLES trial indicate that sirolimus-eluting stent implantation (SES) is a suitable alternative therapeutic approach in these patients.
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
